Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALC vs TALIMOGENE LAHERPAREPVEC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TALC vs TALIMOGENE LAHERPAREPVEC: Safety Overview

Metric TALC TALIMOGENE LAHERPAREPVEC
Total FAERS Reports 933 1,475
Deaths Reported 222 164
Death Rate 23.8% 11.1%
Hospitalizations 69 286
Average Patient Age 56.6 yrs 66.7 yrs
% Female Patients 79.6% 48.3%
FDA Approval Date Dec 15, 2003 N/A
Manufacturer Novatech SA Amgen Inc
Route INTRAPLEURAL INTRALESIONAL
Marketing Status Prescription N/A